Adolescent Psychiatry - Volume 13, Issue 2, 2023

Cannabidiol (CBD), a plant-derived cannabinoid compound found in cannabis, has been readily available in the United States since the legalization of hemp products in 2018. With all 50 states legalizing some form of CBD, many products have appeared in the marketplace. The American public generally considers CBD a safe and effective way to manage pain, mental health conditions, and other health issues in children and adul Read More

Background: COVID-19 pandemic restrictions resulted in psychosocial stress and increased potential for psychiatric disorders in the adolescent population. Adolescent psychiatric disorders are increasingly managed with psychotropic medications. We aimed to evaluate the first-time prescription rates of psychotropic medications128;”antidepressants, antipsychotics, hypnotics, sedatives, mood stabilizers, and psychost Read More

Background: Communication disorders are associated with psychopathology and social distress in adolescents, yet moderate or less severe deficits often go undiagnosed. Data from a quality improvement initiative was analyzed from the Communication Perception Estimate Scale (CoPES), a self-report scale for receptive-expressive and pragmatic language deficits in youth receiving mental health services.Objective: To identify the Read More

Background: Fear of Missing Out (FoMO) on social media has emerged as a significant concern, particularly among college students, with implications for mental well-being and internet use. While previous studies have explored various aspects of mindfulness about digital behaviors, the specific link between mindfulness and FoMO, as well as the potential mechanisms involved, remains underexplored.Objective: Guide Read More